These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11706706)

  • 1. Catalytic antibodies in autoimmune mice.
    Nishi Y; Takahashi N; Kakinuma H; Sun J
    Chem Immunol; 2000; 77():58-79. PubMed ID: 11706706
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved generation of catalytic antibodies by MRL/MPJ-lpr/lpr autoimmune mice.
    Takahashi N; Kakinuma H; Hamada K; Shimazaki K; Yamasaki Y; Matsushita H; Nishi Y
    J Immunol Methods; 2000 Feb; 235(1-2):113-20. PubMed ID: 10675763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evolution of catalytic antibodies in autoimmune mice.
    Sun J; Takahashi N; Kakinuma H; Nishi Y
    J Immunol; 2001 Nov; 167(10):5775-85. PubMed ID: 11698451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice.
    Dubrovskaya VV; Andryushkova AS; Kuznetsova IA; Toporkova LB; Buneva VN; Orlovskaya IA; Nevinsky GA
    Biochemistry (Mosc); 2003 Oct; 68(10):1081-8. PubMed ID: 14616078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?
    Tawfik DS; Chap R; Green BS; Sela M; Eshhar Z
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2145-9. PubMed ID: 7892238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice.
    Andryushkova AA; Kuznetsova IA; Orlovskaya IA; Buneva VN; Nevinsky GA
    Int Immunol; 2009 Aug; 21(8):935-45. PubMed ID: 19556305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catalytic antibodies or "abzymes"].
    Lacroix-Desmazes S; Bayry J; Kazatchkine MD; Kaveri SV
    Med Sci (Paris); 2003 May; 19(5):519-22. PubMed ID: 12836378
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of catalytic (DNA-hydrolyzing) and cytotoxic properties of anti-dna autoantibodies.
    Suchkov SV
    Bull Exp Biol Med; 2001 Apr; 131(4):353-5. PubMed ID: 11550025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.
    Mandik-Nayak L; Seo SJ; Sokol C; Potts KM; Bui A; Erikson J
    J Exp Med; 1999 Jun; 189(11):1799-814. PubMed ID: 10359584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q deficiency and autoimmunity: the effects of genetic background on disease expression.
    Mitchell DA; Pickering MC; Warren J; Fossati-Jimack L; Cortes-Hernandez J; Cook HT; Botto M; Walport MJ
    J Immunol; 2002 Mar; 168(5):2538-43. PubMed ID: 11859149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
    J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of autoantibody production in lpr/lpr mice by transgenic expression of Fas on B cells.
    Shinohara N; Ikegami Y; Yokoyama M; Yonehara S; Komano H
    Ann N Y Acad Sci; 1997 Apr; 815():489-91. PubMed ID: 9186706
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of autoreactive T cells that help nucleobindin-injected mice produce anti-DNA antibodies.
    Kubota T; Watanabe N; Kaneko T; Satake F; Miura K; Kurosawa Y; Miyasaka N; Kanai Y
    Immunol Lett; 2001 Jan; 75(2):111-5. PubMed ID: 11137134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice.
    Iwata Y; Wada T; Furuichi K; Sakai N; Matsushima K; Yokoyama H; Kobayashi K
    J Am Soc Nephrol; 2003 Jan; 14(1):57-67. PubMed ID: 12506138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules.
    Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM
    Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice.
    Kanai Y; Takeda O; Miura K; Amagai M; Kaneko T; Kubota T; Kanai Y; Tanuma S; Kurosawa Y
    Immunol Lett; 1995 Feb; 45(1-2):35-42. PubMed ID: 7622185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG anti-cardiolipin antibodies in murine lupus.
    Gharavi AE; Mellors RC; Elkon KB
    Clin Exp Immunol; 1989 Nov; 78(2):233-8. PubMed ID: 12412755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural antibody catalytic activities in mice with autoimmune disorders.
    Ponomarenko NA; Aleksandrova ES; Vorobiev II; Durova OM; Kozyr AV; Kolesnikov AV; Telegin GB; Kalinina AR; Suchkov SV; Gabibov AG
    Dokl Biochem; 2000; 375():224-7. PubMed ID: 11296476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.